Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03700684 · ClinicalTrials.gov registry record · NA

Voice Treatment for Parkinson's Disease

A NA study of Idiopathic Parkinson Disease, sponsored by University of Massachusetts, Amherst.

Completed
Registry status
NA
Development phase
36
Enrollment target
2
Study locations

NCT03700684 is a NA study of Idiopathic Parkinson Disease that has completed, run by University of Massachusetts, Amherst. The registered enrollment target is 36 participants, below the 69-participant average among 4 other Idiopathic Parkinson Disease trials with a reported enrollment target (48% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03700684, a NA study of Idiopathic Parkinson Disease, has completed, sponsored by University of Massachusetts, Amherst.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

This study addresses several issues related to the clinical management of speech and voice disorders associated with Parkinson's disease. Two behavioral treatment programs, Lee Silverman Voice Treatment and SpeechVive, are assessed in their ability to improve communication in persons with Parkinson's disease.

Conditions Studied

Idiopathic Parkinson Disease

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Lee Silverman Voice Treatment
  • DEVICE SpeechVive

Study Locations (2)

Indiana

  • Purdue University - West Lafayette

Massachusetts

  • University of Massachusetts Amherst - Amherst

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2018-09-19
Est. Completion 2022-11-30
Phase NA

Sponsor

University of Massachusetts, Amherst

33 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03700684

The ClinicalTrials.gov registry entry for NCT03700684 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 69-participant average among 4 other Idiopathic Parkinson Disease trials with a reported enrollment target (48% lower). The listed sponsor is University of Massachusetts, Amherst, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Idiopathic Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT03700684 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03700684 about?

NCT03700684 is a clinical study titled "Voice Treatment for Parkinson's Disease". This study addresses several issues related to the clinical management of speech and voice disorders associated with Parkinson's disease. Two behavioral treatment programs, Lee Silverman Voice Treatment and SpeechVive, are assessed in their ability to improve communication in persons with Parkinson'...

What is the current status of trial NCT03700684?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-09-19. Estimated completion is 2022-11-30.

What conditions does trial NCT03700684 study?

This clinical trial studies the following conditions: Idiopathic Parkinson Disease.

What interventions are being tested in trial NCT03700684?

The interventions under investigation include: Control (BEHAVIORAL), Lee Silverman Voice Treatment (BEHAVIORAL), SpeechVive (DEVICE).

Who is sponsoring clinical trial NCT03700684?

This trial is sponsored by University of Massachusetts, Amherst, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03700684 being conducted?

This trial has 2 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Idiopathic Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Idiopathic Parkinson Disease

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.